We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


RedShiftBio Welcomes Sebastian Arevalo As New Sales Leader

A scientist working in a lab.
Credit: iStock.
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

RedShiftBio is thrilled to announce the appointment of Sebastian Arevalo as Vice President of Sales. With over two decades of experience in the biotechnology and life sciences sectors, Sebastian brings a wealth of expertise and a proven track record of driving revenue growth.

Sebastian's career trajectory is marked by his remarkable achievements and his relentless pursuit of excellence. Before joining RedShiftBio, he held various key positions at Bio-Techne, where he rose through the ranks to become the Senior Commercial Sales Director of North America, leading the analytical instrumentation division to unprecedented success.

Throughout his tenure in industry-leading biotech companies including ProteinSimple, Eppendorf, New Brunswick Scientific, and Pall Corporation, Sebastian consistently surpassed sales targets and spearheaded substantial year-over-year growth initiatives. His dynamic leadership style and unwavering commitment to success have earned him a reputation as a charismatic and results-driven leader.

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

Sebastian's academic background includes a Bachelor of Science degree in Engineering from Northeastern University, laying the groundwork for his future success in the biotechnology landscape.

At RedShiftBio, Sebastian will leverage his passion for driving growth and delivering exceptional results to further propel the company's success with the Aurora and HaLCon platforms. His visionary leadership and dedication to excellence will undoubtedly shape the future of the organization as RedShiftBio continues to innovate and make technological strides in protein characterization, RNA structure analysis, and bioprocess development tools.